Daphne Quimi, VP Finance and Controller at AMICUS THERAPEUTICS INC (FOLD), sold 16,812 shares at $10.84 ($182K) on 2015-05-11, disclosed to the SEC on 2015-05-12.
Scheduled sale ($182k) by VP Finance and Controller under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.80 | 9,312 | $101K | 55.3% |
| 2 | $10.84 | 7,500 | $81K | 44.7% |
| Total | $10.82 avg | 16,812 | $182K | 100% |
| Filing → |
| FOLD | SELL | 2023-01-19 | $152K | — | Filing → |
| FOLD | SELL | 2022-09-06 | $50K | — | Filing → |
| FOLD | SELL | 2022-08-09 | $70K | — | Filing → |